Ho Chi Sing 13D/13G Filings for CASI Pharmaceuticals, Inc. (CASI)

Ho Chi Sing 13D and 13G filings for CASI Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-02-03
8:17 pm
Purchase		 2024-12-30 13D CASI Pharmaceuticals, Inc.
CASI		 Ho Chi Sing 992,638
6.400%		 992,638increase
(New Position)		 Filing